{"rows":[{"id":4806,"title":"A regulatory framework review of Schedule I psychedelics in the United States","authors":"Kevin Herkenham","journal":"JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY","publication_date":"2023-06-12","publication_year":2023,"doi":"10.1002/jac5.1841","pubmed_id":null,"openalex_id":"https://openalex.org/W4380357539","source_url":"https://doi.org/10.1002/jac5.1841","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Review Article,Healthcare Workers,Safety,Toxicity","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:45","last_checked":"2026-08-09 08:25:35","bibtex":null,"source_record_id":"DOI:10.1002/jac5.1841","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1002/jac5.1841","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1002/jac5.1841","source_url":"https://doi.org/10.1002/jac5.1841","doi":"10.1002/jac5.1841","pmid":"","publication_date":"2023-06-12","importer_version":"2.1.3","text_redistributed":false}}],"total":1,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}